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Wereportacaseof29yearsoldwomanwhowasdiagnosedwithacutefattyliverofpregnancyat23weeksofgestationwithunusual
evolution (pregnancy prolonged until 36 weeks of gestation) to draw attention on the possibility of occurrence of this pathology
in the second trimester of pregnancy even with a milder clinical presentation and course.
1.Introduction
Acute fatty liver of pregnancy (AFLP) is an uncommon, life-
threateningcomplicationthatoccursinthethirdtrimesteror
early postpartum period [1]. In the literature, only few cases
of acute fatty liver of pregnancy in the second trimester were
reported [2, 3]. Here, we report a case of AFLP with a milder
clinical presentation in the second trimester.
2.CaseReport
A 29-year-old woman, gravid 1, presented at 23 weeks’
gestation with nausea, vomiting, abdominal pain, malaise,
and weight loss. An ultrasound at 11 weeks’ gestation deter-
mined gestational age. She was normotensive with a normal
platelet count and no proteinuria. She had elevated liver
transaminaselevels(aspartateaminotransferase[ASAT]level
108U/L, alanine aminotransferase [ALAT] level 104U/L),
prothrombin time [PT] 96%, negative hepatitis serology (A,
B, C, and E), and a negative immunologic analysis. She was
treated with intravenous ﬂuids, but we remarked a slightly
aggravation of her laboratory ﬁndings ASAT 122U/L, ALAT
248U/L, GGT 18U/L, PAL 118U/L, bilirubin total/direct
23,2/17,4µmol/L, PT 76%, WBC 7800, platelets 178000,
glucose 65mg/dL, and uric acid 246µmol/L. The abdominal
ultrasoundshowedabrilliantliverwithoutothersanomalies.
Because of the doubt on diagnosis and stable clinical and
biologic parameters, a liver biopsy was performed (10
days after admission) and showed a microvesicular fatty
inﬁltrationofthehepatocytes(Figure 1).Adiagnosisofacute
fatty liver of pregnancy was conﬁrmed. The decision was
to prolong the pregnancy under surveillance in obstetric
unit care with clinical and biological control. The biological
analyses were stable (Table 1) with good clinical condition.
The evolution was good and the pregnancy was prolonged
until 36 weeks of gestation, and the patient gave birth to a
healthy newborn of 2900g, Apgar score of 9/10. The delivery
was simple without any complications. After delivery, all
biologic parameters were normalized within 7–10 days and
the patient was discharged.
3. Comments
Acute fatty liver of pregnancy is a rare and potentially fatal
condition. It has been thought that this condition is rare and
usually takes a devastating course with signiﬁcant morbidity
and mortality [1], incidence is estimated to be 1/1000 to
1/20000 deliveries [1], and, generally, it occurs in the third
trimester or early postpartum period of pregnancy, but a
few cases in the second trimester were published [2, 3].2 Case Reports in Obstetrics and Gynecology
Table 1: Biologic analysis evolution.
Day after admission 1 3 7 21 42 63 84 91
ALAT IU/L 104 248 213 165 172 146 134 145
ASAT IU/L 108 122 104 106 110 96 98 102
PAL IU/L 138 118 123 121 142 134 129 119
BIL T µmol/L 14 23,2 18,4 16,7 14,5 16 15,8 17,3
BIL D µmol/L 8,5 17,4 12,6 11,2 10,4 12,1 11,3 12,9
Creatinine µm o l / L 6 47 86 75 66 46 17 35 7
Uric acid mmol/L 144 138 145 164 154 151 167 173
Hemoglobin g/dL 12,2 12,3 11,9 12 11,5 11,7 11,4 11,8
Platelets/mm3 213000 178000 198000 187000 201000 221000 197000 184000
WBC 7600 7800 8500 9200 7400 10100 10700 12000
PT % 96% 76% 78% 81% 92% 84% 79% 85%
Glucose mmol/L 3,6 4 4,9 5,1 4,4 5,3 4,8 5,5
WBC: white blood cell.
PT: prothrombin time.
ASAT: aspartate aminotransferase.
ALAT: alanine aminotransferase.
Figure 1
Furthermore, modern advances in diagnostic capabilities
have given us a better understanding of the pathological pro-
cess, and many cases with a milder clinical course as well as
subclinical cases have been reported [4–6]. Our observation
isunusualbyitsclinicalevolutionuntiltermandtimeofaris-
ing (second trimester). Indeed, Monga and katz [2]r e p o r t e d
a case of AFLP arising at 22 weeks’ gestation in 35 years
women. However, in this case evolution was interrupted
because of a disseminated intravascular coagulation.
Also, Suzuki et al. [3] reported a case arising at 23 weeks
of gestation for which the interval between symptom occur-
rence and fetal demise was only one week and pregnancy was
quickly interrupted.
Curiously, biological ﬁndings in our observation were
constant during evolution of pregnancy, particularly, pro-
thrombin test and platelet counts. These ﬁndings may
conﬁrm the cases with subclinical or milder clinical course
already reported.
Usually, there is no speciﬁc treatment for acute fatty liver
of pregnancy except prompt termination of pregnancy and
pathological changes as a rule improve rapidly after delivery.
Liver biopsy is the best way to conﬁrm the diagnosis, but
because it is invasive, it is not always performed. Further-
more,todaywecantakeadvantageofnoninvasiveprocedures
to demonstrate fat in the liver and to exclude other liver
diseases such as viral hepatitis [7]. Histopathological ﬁnding
in liver biopsies is small and midsized intracellular vacuoles,
without displacement of the nucleus and ballooning hepato-
cytes.
Recently, an association between AFLP and a deﬁciency
oftheenzymelong-chain3-hydroxyacyl-CoAdehydrogenase
was suggested. This enzyme is one of the four enzymes,
which break down long-chain fatty acids in the liver.
Deﬁciency of this enzyme results in the increased accu-
mulation of long-chain fatty acids [8]. However, the exact
mechanism that explains these mild clinical presentations
remains unknown.
This case, one of few reported cases, shows that even in
the second trimester, the diagnosis of acute fatty liver should
be considered when a woman presents with deteriorating
liver function, jaundice, and coagulopathy. The particularity
of this case is the unusual evolution; with a stable clinical
and biological perturbations for 13 weeks after diagnosis of
AFLP. Finally, the diagnosis of AFLP must be suspected in
front of all digestive symptomatology in the second or the
third trimester of pregnancy.
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